Bloom Burton Stock Recommendations and Price Targets

This is a list of recent ratings by Bloom Burton.

Date	Company Name	Action	Current Price	Price Target	Rating	Impact on Share Price
5/2/2024	CYBN Cybin	Reiterated Rating	$10.00		Buy	Low
4/19/2024	RPTX Repare Therapeutics	Upgrade	$1.00		Accumulate ➝ Buy	Low
2/13/2024	RPTX Repare Therapeutics	Downgrade	$1.00		Buy ➝ Accumulate	Low
1/4/2024	MBX Microbix Biosystems	Reiterated Rating	C$0.00		Buy	N/A
11/3/2023	ABCL AbCellera Biologics	Reiterated Rating	$3.00		Buy	Low
6/26/2023	MDP Medexus Pharmaceuticals	Upgrade	C$3.00		Hold ➝ Buy	N/A
3/23/2023	RX BioSyent	Reiterated Rating	C$12.00		Accumulate	N/A
11/16/2022	DOC CloudMD Software & Services	Upgrade	C$0.00		Hold ➝ Accumulate	N/A
8/24/2022	DOC CloudMD Software & Services	Downgrade	C$0.00		Buy ➝ Hold	N/A
8/16/2022	MDNA Medicenna Therapeutics	Lower Price Target	C$2.00	C$9.00	Buy	N/A
7/28/2022	MDNA Medicenna Therapeutics	Reiterated Rating	C$2.00	C$11.00	Buy	N/A
7/26/2022	HLS HLS Therapeutics	Reiterated Rating	C$4.00	C$22.00	Buy	N/A
6/6/2022	MBX Microbix Biosystems	Reiterated Rating	C$0.00		Buy	N/A
5/13/2022	MRV Nuvo Pharmaceuticals	Downgrade	C$1.00		Buy ➝ Hold	N/A
3/28/2022	GUD Knight Therapeutics	Reiterated Rating	C$5.00	C$6.70	Buy	N/A
3/25/2022	GUD Knight Therapeutics	Downgrade	C$5.00		Buy ➝ Accumulate	N/A
3/10/2022	RX BioSyent	Upgrade	C$12.00		Hold ➝ Accumulate	N/A
12/22/2021	DOC CloudMD Software & Services	Reiterated Rating	C$0.00		Buy	N/A